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Background: Obesity is a major risk factor for type 2 diabetes mellitus (T2DM). A proper anthropometric
characterisation of T2DM risk is essential for disease prevention and clinical risk assessement.
Methods: Longitudinal study in 37 733 participants (63% women) of the Spanish EPIC (European Prospective
Investigation into Cancer and Nutrition) cohort without prevalent diabetes. Detailed questionnaire information was
collected at baseline and anthropometric data gathered following standard procedures. A total of 2513 verified
incident T2DM cases occurred after 12.1 years of mean follow-up. Multivariable Cox regression was used to
calculate hazard ratios of T2DM by levels of anthropometric variables.
Results: Overall and central obesity were independently associated with T2DM risk. BMI showed the strongest
association with T2DM in men whereas waist-related indices were stronger independent predictors in women.
Waist-to-height ratio revealed the largest area under the ROC curve in men and women, with optimal cut-offs at
0.60 and 0.58, respectively. The most discriminative waist circumference (WC) cut-off values were 99.4 cm in men
and 90.4 cm in women. Absolute risk of T2DM was higher in men than women for any combination of age, BMI
and WC categories, and remained low in normal-waist women. The population risk of T2DM attributable to obesity
was 17% in men and 31% in women.
Conclusions: Diabetes risk was associated with higher overall and central obesity indices even at normal BMI and
WC values. The measurement of waist circumference in the clinical setting is strongly recommended for the
evaluation of future T2DM risk in women.
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Obesity is recognised as a major cause of type 2 diabetes
mellitus (T2DM) [1-4]. Changing lifestyles over the last
decades have given rise to a global epidemic of over-
weight and obesity which has spread from developed to
developing countries and from adults to children and
adolescents [5-7]. In 2000, 15% of the Spain population
were obese [8], and 9% suffered from T2DM [9]. If
trends remain unchanged, conservative estimates are
that 12% of the country population will be diabetic by
2030 [9]. The associated future burden of chronic dis-
eases and health costs of the obesity epidemic are of ser-
ious concern.
Obesity is defined by the accumulation of excess body
fat with potential harmful health effects [10]. A strong
link between excess body weight and T2DM risk has
long been established in the epidemiological literature.
Further evidence showed that ectopic visceral fat accu-
mulation, but not subcutaneous adipose tissue [11],
largely accounted for the metabolic complications of
obesity [12], such as abnormalities in glucose and lipid
metabolism [13] and hepatic insulin resistance [13,14],
preceding the development of T2DM.
Anthropometry provides the universal basis for the
clinical identification of obese people because the an-
thropometric methodology is easy to implement, inex-
pensive, and valid. Simple measures such as height,
weight or waist and hip circumferences characterise
overall and regional adiposity near as accurately as
sophisticated reference methods [11]. The body mass
index (BMI), which reflects body general adiposity, is
valid for defining obesity at the population level but does
not properly account for the wide variation in body fat
distribution within individuals [10,15]. BMI does not dif-
ferentiate between fat and muscle mass [15], follows a
non-linear association with body fat percent [16] and is
poorly prognostic of obesity-related co-morbidities in
subjects of short stature [17] or older age [18]. A proper
characterisation of obesity-associated risk requieres that
at least one indicator of visceral fat depots is measured.
Waist measures such as waist circumference (WC) or
waist-to-hip ratio (WHR) are stronger proxies for ab-
dominal obesity than body mass index [11,19]. Even for
narrow ranges of BMI large differences in WC exist that
account for sizeable variations in risk of chronic condi-
tions such as diabetes or cardiovascular disease [12,20],
suggesting that indices of general and central adiposity
provide complementary information. On an individual
basis, there is discrepancy about which measure would
better predict risk of T2DM as two previous meta-analyses
found no clear differences for BMI, WC or WHR as pre-
dictors of diabetes [21,22]. A further recent meta-analysis
suggested that waist-to-height ratio (WHtR) would show a
superior predictive ability than BMI or WC, although oflimited clinical utility [23]. Using a combination of an-
thropometric measures to account for both the amount
and distribution of body fat seems the best way of charac-
terising obesity-associated T2DM risk [1,2]. Body propor-
tions related to height, such as the WHtR, relative height
or leg length, cause further variations in BMI which are
not associated with body fat percent [24,25], and may pro-
vide additional insight into the association of obesity and
T2DM [1,26-28].
Given the aetiologic effect of excess body fat on T2DM
and in order for preventive actions to be effective, the
most accurate tools for the early identification of at-risk
subjects must be adopted. No specific cut-offs exist yet for
defining central obesity in Spanish population on the basis
of WC and there is little prospective evidence in sup-
port of the appropriateness of applying American [29] or
European [30] standards to the country population. The
main objective of the present study was to obtain specific
estimates of diabetes risk in Spain according to different
anthropometric variables in a large cohort of participants
from the European Prospective Investigation into Cancer
and Nutrition (EPIC)-Spain study, and to define those an-
thropometric values that would better predict future risk
of T2DM in this population.
Methods
Study sample
The EPIC (European Prospective Investigation into Cancer
and Nutrition) Study is an ongoing multi-centre prospect-
ive cohort study on diet, genetic and environmental
factors and health. The study cohort involves over half a
million participants from 10 European countries. The
Spanish branch of EPIC comprises 41 438 participants
mostly 30–65 years old at the time of enrolment (1992–
1995). Participants were recruited mainly among blood
donnors but also civil servants and general population
from five Spanish regions, three in the North (Asturias,
Gipuzkoa and Navarra) and two in the South (Granada
and Murcia). Baseline data collection included the measure
of anthropometric variables and questionnaire information
on diet, lifestyles, medical history and drug consumption,
as detailed elsewhere [31,32].
All participants voluntarily agreed to take part in the
study and gave informed consent. Ethical approval was
granted by the Medical Ethical Committee of Bellvitge
Hospital.
Assessment of anthropometric variables
Participants were invited to attend a physical examin-
ation in order to obtain relevant anthropometric infor-
mation, according to standardised procedures. Height
was registered by having the subjects barefoot and in up-
right position. With participants seated, sitting height
was defined as the length from the seat to the top of the
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ting height. The sitting height ratio was then calculated
as sitting-height divided by standing height. Weight was
assessed with subjects in light underwear using a digital
scale with a precision of 0.1 kg. Waist circumference was
measured at the narrowest torso circumference for most
participants, but the midpoint between the lower ribs
and the iliac crest was used instead if the natural waist
could not be identified. Finally, hip circumference was
registered at the widest diameter of the buttocks. Height,
and waist and hip circumferences were measured to the
nearest 1 cm.
Body mass index was obtained as weight (in kg)
divided by square height (in m). Waist-to-hip and waist-
to-height ratios were computed as the quotient between
waist and hip circumferences and between WC and
height (in cm), respectively.
Full anthropometric data was available for 98.4% of
participants.Identification of incident diabetes cases
A total of 2560 verified incident T2DM cases occurred
between recruitment and December 31st, 2006 (mean
follow-up time of 12.1 years). A sensitive approach was
used for the ascertainment of T2DM cases based upon
different sources of information including self-reported
diabetes or consumption of diabetes medication during a
follow-up interview 3 years after recruitment, hospital
discharge databases, drug prescription records, and re-
gional mortality registers and the National Death Index,
for all centres, and record linkage with primary care reg-
isters for all centres except Granada (where access to
primary care data was partly available for case verifica-
tion, however). Furthermore, access to laboratory data
on glycaemia and glycosilated hemoglobin (HbA1c) tests
was available in Gipuzkoa.
Verification of possible T2DM cases was carried out
by a team of trained health professionals by careful revi-
sion of clinical data and health information from all
available sources. A definite case was defined if a phys-
ician diagnosis of type 2 diabetes was present in the
medical history or otherwise evidence of diabetes from
two independent sources (depending on study centre),
according to the following criteria, 2-hour post-load gly-
caemia value ≥ 200 mg/dl after a 75-g oral glucose toler-
ance test (OGTT), HbA1c > 7%, fasting plasma glucose ≥
126 mg/dl, non-fasting glycaemia ≥ 200 mg/dl, diabetes
related medical visit (code E11._ of the 10th revision of
the International Classification of Diseases (ICD-10)),
self-report of diabetes, use of antidiabetic medication (A10
code of the World Health Organization Anatomical
Therapeutic Chemical classification system [33]), or death
certificate with ICD-10 code E11.Incidence date was defined either as the earliest date of
diagnosis or first antidiabetic drug use registered in the
medical records, or the date of self-report. If only informa-
tion on the month or year was available, the date of dia-
betes onset was defined at the middle of the corresponding
period. For self-reported cases, when several self-reports
were available, the incidence date was imputed at the mid-
point between the date of the first positive report of
diabetes by the participant and the previous negative self-
report. Time at risk was calculated as the difference be-
tween age at T2DM diagnosis, death, or lost to follow-up,
whichever occurred first, and age at recruitment. The ascer-
tainment and verification process of T2DM cases followed
the criteria and procedures defined in the EPIC-InterAct
study. Further details can be found elsewhere [34].
Exclusions affected prevalent T2DM cases (n = 2383),
participants with missing follow-up data on diabetes sta-
tus (n = 713) and four non-type 2 diabetics. Participants
with implausible anthropometric values (height < 130 cm;
BMI < 16 kg/m2; WC> 160 cm; or WC< 60 cm and BMI >
25 kg/m2) (n = 6), or missing data on anthropometry (n =
599) were further excluded. Finally, 14 019 men and 23 714
women completing 2513 incident cases of diabetes and
near 457 000 person-years were available for analysis.
Covariate assessment
Information on habitual diet of the previous year was
gathered by means of a validated dietary history met-
hod during a personnal interview. Correction for mis-
reporting of energy inake was applied by classifying
participants as under-reporters, plausible reporters and
over-reporters according to the predicted total energy
expenditure (pTEE) method, as described by Méndez
et al. [35]. A daily consumption of alcohol between 10–
50 g in men and 5–25 g in women was regarded as
‘moderate’, with ‘low’ and ‘high’ consumption groups
defined outside these ranges. Information was also col-
lected on smoking status (never, former, current, un-
known), educational level (primary school or lower,
secondary or technical/professional school, university,
unknown), and practice of recreational activities. Total
MET-hours/week in walking, cycling and sports were
computed to derive a four-category recreational phys-
ical activity index: inactive, moderately inactive, moder-
ately active, active.
Statistical analyses
Descriptive statistics by sex and diabetes status included
median and interquartile range for continuous variables,
and absolute and relative frequencies for categorical
ones. Mann–Whitney U tests or χ2 test were applied to
evaluate differences in the distribution of the data by
diabetes status, as appropriate. Analyses were performed
separately for men and women.
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anthropometric variables were computed for men and
women separately taking the lowest quartile as the refer-
ence. Cox proportional hazards models were built with
attained age as the time variable (entry time defined as
age at recruitment and exit time defined as age at inci-
dent diabetes or age at censoring). Cox models were
stratified by centre, age (in five-year categories), and
follow-up time (<5 years, 5–10 years, ≥10 years). The
validity of the proportional hazards assumption was
tested on the basis of Schoenfeld residuals. All analyses
were controlled for total energy intake, plausibility of en-
ergy reporting, alcohol intake level, smoking status, edu-
cational attainment, recreational physical activity index,
and menopausal status, in women. In order to analyse
the independency of the reported associations, BMI
models were further adjusted for WC, and central obes-
ity models were adjusted for height and weight. Other
covariates such as dietary (consumption of proteins,
lipids, carbohydrates, red meat, processed meat, tea,
coffee, fiber, and magnesium), or parity variables (in
women), had no significant influence on risk estimates
and were not included in the final models. Furthermore,
several sensitivity analyses were conducted in order to
test the robustness of results by excluding participants
with short follow-up or chronic conditions at baseline,
or by stratifying the results by categories of age, follow-
up time and menopausal status.
The area under the receiver operating characteristic
(ROC) curve was estimated for selected anthropometric
variables and optimal cutoffs were defined at the maximum
Youden index (J = sensitivity + specificity – 1). Sensitivity
and specificity values were also computed for WC at the
National Cholesterol Education Program-Adult Treatment
Panel III (NCEP-ATPIII) and International Diabetes
Federation (IDF) cutoffs.
The 10-year cumulative incidence of diabetes was cal-
culated according to NCEP-ATPIII waist categories,
stratified by BMI (normal weight, overweight, obese),
sex, and age group (40–49, 50–59, 60–69 years), as theTable 1 Incidence rates of diabetes in the Spanish EPIC (Euro
cohort, by sex and center
Men
Person-years Cases Crude rate Truncated standardised ra
Total 170499 1278 750 605 (565–645)
Asturias 35031 258 737 613 (512–714)
Gipuzkoa 45155 345 764 567 (507–628)
Navarra 43894 342 779 572 (511–634)
Granada 18572 99 533 421 (334–507)
Murcia 27847 234 840 725 (321–829)
Rates per 100 000 person-years (with 95% confidence intervals) for the 30–64 age b
1 Adjusted to the European Standard Population using the direct method.cumulative number of cases at 10 years of follow-up
divided by the total population in each stratum.
The population risk of diabetes attributable to excess
body weight was calculated as pd (RR - 1)/RR; where pd =
prevalence of exposition among cases, and RR =multivari-
able-adjusted hazard ratio of diabetes in exposed versus
non-exposed participants [36].
Non-linear associations of diabetes risk with BMI and
WC were also modelled using restricted cubic splines with
sex-specific distribution-based knots at the 5th, 25th, 50th,
75th and 95th percentiles of BMI and WC. Relative hazards
of diabetes derived from adjusted Cox models were then
plotted against continuous variables. Nelson-Aalen cumula-
tive hazard estimates by BMI and WC categories were plot-
ted separately for men and women.
Analyses were performed using STATA 10.1 (StataCorp
LP, College Station, USA). All tests were two-sided and
P-values < 0.05 were considered significant.Results
As shown in Table 1, the incidence of diabetes was higher
in men than women, not showing clear geographical pat-
terns. Cases were, in general, older, fatter, less educated,
and less physically active (Table 2). In addition, diabetic
men were more prone to smoke, as opposed to diabetic
women. Overall, differences in anthropometric variables
between cases and non-cases were larger in women.
Table 3 shows the main results of the sex-specific ana-
lyses of diabetes risk by quartiles of anthropometric indi-
ces of general (BMI), gluteo-femoral (hip circumference),
and central obesity (WC, WHR, or WHtR). The estimated
risk of diabetes was generally higher for any level increase
of body mass index or waist-related variables. Point esti-
mates of T2DM risk (Q4 vs. Q1) ranged from 1.5 for hip
circumference to 2.6 for BMI, in men, and from 2.5 for
hip circumference to 7.9 for WHtR, in women. Adjust-
ment of BMI models for indices of central obesity did not
affect the estimation of diabetes risk in men, but led to an
attenuation of risk estimates in women. All variablespean Prospective Investigation into Cancer and Nutrition)
Women
te1 Person-years Cases Crude rate Truncated standardised rate1
290047 1252 432 407 (380–433)
64689 266 411 399 (345–453)
50635 195 385 355 (304–405)
48810 239 490 433 (378–488)
62464 245 392 354 (310–399)
63450 307 307 433 (378–488)
and.
Table 2 Baseline general and anthropometrical characteristics of diabetic and non-diabetic members of the Spanish
EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, by sex
Men Women
Non-cases Cases Non-cases Cases
Median IQR Median IQR Median IQR Median IQR
Age (years) 49.3 11.6 52.2 11.4 47.1 13.3 51.9 12.1
Height (cm) 169.0 8.4 168.0 7.9 157.0 7.8 155.2 8.0
Weight (kg) 80.0 13.4 84.5 15.4 66.8 13.8 76.4 16.8
Waist circumference (cm) 98.0 11.0 103.5 12.0 85.0 15.0 97.0 14.0
Hip circumference (cm) 104.0 7.7 106.6 9.0 104.0 11.0 111.0 14.0
Sitting height (cm) 87.3 5.3 86.8 4.9 82.7 4.7 82.2 4.8
Leg length (cm) 81.8 6.3 81.0 6.3 74.2 5.8 73.0 5.6
Body mass index (kg/m2) 27.9 4.1 30.0 4.5 27.1 5.9 31.8 6.5
Waist-to-hip ratio 0.94 0.06 0.97 0.06 0.82 0.08 0.86 0.07
Waist-to-height ratio 0.58 0.07 0.62 0.07 0.54 0.10 0.63 0.09
N % N % N % N %
BMI categories1
Normal weight 1876 14.7 68 5.3 6637 29.5 63 5.1
Overweight 7572 59.4 569 44.7 9658 43.0 379 30.5
Obese 3299 25.9 635 49.9 6178 27.5 799 64.4
WC categories2
Low 3619 28.4 132 10.4 6582 29.3 48 3.9
Medium 4813 37.8 409 32.2 6501 28.9 175 14.1
High 4315 33.9 731 57.5 9390 41.8 1018 82.0
Educational level
Primary or lower 7599 59.6 924 72.6 16524 73.5 1032 83.2
Secondary 2748 21.6 225 17.7 2631 11.7 62 5.0
University 2026 15.9 76 6.0 2260 10.1 26 2.1
Unknown 374 2.9 47 3.7 1058 4.7 121 9.8
Smoking
Never smoker 3864 30.3 290 22.8 15699 69.9 1012 81.5
Former smoker 3861 30.3 360 28.3 2340 10.4 71 5.7
Smoker 5016 39.4 620 48.7 4422 19.7 158 12.7
Unknown 6 0.1 2 0.2 12 0.1 0 0
Recreational physical activity index3
Inactive 4353 34.1 472 37.1 8728 38.8 531 42.8
Moderately inactive 3241 25.4 350 27.5 7447 33.1 387 31.2
Moderately active 2765 21.7 258 20.3 4351 19.4 222 17.9
Active 2388 18.7 192 15.1 1947 8.7 101 8.1
Menopausal status
Pre-menopausal - - 12530 55.8 449 36.2
Peri-menopausal - - 2109 9.4 141 11.4
Post-menopausal - - 7834 34.9 651 52.5
BMI: body mass index, WC: waist circumference.
All within-sex comparisons between cases and non-cases were significant at P< 0.001 level, except for the recreational physical activity index (Pmen= 0.003; Pwomen= 0.051).
1 Normal weight, BMI < 25 kg/m2; overweight, 25 ≤ BMI < 30 kg/m2; obese, BMI ≥ 30 kg/m2.
2 Low, WC< 94 cm (men) or WC< 80 cm (women); medium, 94≤WC<102 cm (men) or 80≤WC< 88 cm (women); high, WC≥ 102 cm (men) or WC≥ 88 cm (women).
3 Sum of MET-h/week spent in walking, cycling and sports. Inactive, ≤19.50; moderately inactive, 19.51-33.75; moderately active, 33.76-54.75; active, >54.75.
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Table 3 Hazard ratio (HR) of diabetes by quartiles of anthropometrical indices in men and women from the Spanish
EPIC (European Prospective Investigation into Cancer and Nutrition) cohort
Men Women
Py Cases HR1 95% CI HR2 95% CI Py Cases HR1 95% CI HR2 95% CI
Body mass index
Q1 43152 135 1 1 73322 52 1 1
Q2 43115 211 1.57 1.27 - 1.97 1.58 1.25 - 2.00 73311 132 1.51 1.08 - 2.11 1.26 0.90 - 1.77
Q3 42155 343 2.02 1.63 - 2.50 2.07 1.64 - 2.61 71690 331 2.89 2.12 - 3.95 2.11 1.52 - 2.93
Q4 40657 583 2.57 2.08 - 3.16 2.68 2.05 - 3.50 69564 726 4.14 3.04 - 5.64 2.48 1.73 - 3.57
Waist circumference
Q1 43948 118 1 1 79543 43 1 1
Q2 42483 230 1.58 1.25 - 1.99 1.49 1.18 - 1.90 72348 137 2.19 1.52 - 3.14 2.02 1.40 - 2.91
Q3 42502 353 1.92 1.54 - 2.40 1.74 1.37 - 2.22 69726 320 4.02 2.85 - 5.68 3.47 2.44 - 4.95
Q4 40146 571 2.32 1.86 - 2.86 1.93 1.46 - 2.55 66272 741 5.93 4.21 - 8.36 4.57 3.12 - 6.68
Hip circumference
Q1 42690 197 1 1 75803 100 1 1
Q2 44831 273 1.13 0.93 - 1.38 1.00 0.82 - 1.23 71293 192 1.56 1.21 - 2.02 1.24 0.96 - 1.61
Q3 40094 317 1.49 1.23 - 1.80 1.21 0.98 - 1.49 74551 335 1.98 1.56 - 2.52 1.24 0.96 - 1.60
Q4 41464 485 1.49 1.24 - 1.79 0.99 0.78 - 1.27 66241 614 2.50 1.97 - 3.17 1.00 0.73 - 1.35
Waist-to-hip ratio
Q1 49640 170 1 1 79106 80 1 1
Q2 38989 226 1.28 1.04 - 1.57 1.17 0.95 - 1.45 77254 208 1.59 1.21 - 2.10 1.50 1.14 - 1.98
Q3 47330 450 1.65 1.37 - 2.00 1.48 1.22 - 1.80 69546 337 2.27 1.74 - 2.97 1.98 1.52 - 2.60
Q4 33121 426 1.63 1.34 - 1.99 1.30 1.05 - 1.60 61983 616 3.18 2.46 - 4.12 2.67 2.06 - 3.47
Waist-to-height ratio
Q1 43815 105 1 1 73889 30 1 1
Q2 43545 224 1.53 1.20 - 1.96 1.48 1.15 - 1.89 73835 132 2.91 1.92 - 4.41 2.79 1.76 - 4.06
Q3 41515 365 2.05 1.62 - 2.59 1.91 1.50 - 2.42 71746 314 5.00 3.34 - 7.49 4.54 2.79 - 6.40
Q4 40204 578 2.32 1.84 - 2.93 2.07 1.60 - 2.69 68418 765 7.91 5.30 - 11.82 6.80 4.45 - 10.39
Py: person-years, HR: hazard ratio, CI: confidence interval.
1 Models stratified by centre, age, and follow-up time, and adjusted by total energy intake, plausibility of energy reporting, alcohol intake, smoking status,
educational level and recreational physical activity.
2 Multivariable models mutually adjusted by height, weight, and waist and hip circumferences, as applicable. Covariates, total energy intake, plausibility of energy
reporting, alcohol intake, smoking status, educational level, physical activity, and menopausal status (women). Models were stratified by centre, age, and
follow-up time.
Cut-off points,
Body mass index (kg/m2), 26.12 (Q1-Q2), 28.10 (Q2-Q3), 30.34 (Q3-Q4) [men]; 24.64 (Q1-Q2), 27.37 (Q2-Q3), 30.74 (Q3-Q4) [women].
Waist circumference (cm), 93.0 (Q1-Q2), 98.8 (Q2-Q3), 104.5 (Q3-Q4) [men]; 79.0 (Q1-Q2), 86.0 (Q2-Q3), 94.0 (Q3-Q4) [women].
Hip circumference (cm), 100.5 (Q1-Q2), 104.5 (Q2-Q3), 108.8 (Q3-Q4) [men]; 99.0 (Q1-Q2), 104.5 (Q2-Q3), 111.0 (Q3-Q4) [women].
Waist-to-hip ratio, 0.91 (Q1-Q2), 0.94 (Q2-Q3), 0.98 (Q3-Q4) [men]; 0.78 (Q1-Q2), 0.82 (Q2-Q3), 0.86 (Q3-Q4) [women].
Waist-to-height ratio, 0.55 (Q1-Q2), 0.58 (Q2-Q3), 0.62 (Q3-Q4) [men]; 0.50 (Q1-Q2), 0.55 (Q2-Q3), 0.60 (Q3-Q4) [women].
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ally adjusted models, except hip circumference.
The areas under the ROC curves for the principal an-
thropometric variables considered are shown in Table 4.
On an individual basis, WHtR revealed the highest area
for both sexes, with optimal sensitivity/specificity cut-
offs at 0.60 in men and 0.58 in women, as defined by the
Youden’s J statistic. Table 5 shows the comparison of
discriminatory ability of several anthropometric cut-offs
in regard to T2DM. Although more sensitive, the IDF
criterion showed poorer specificity (<30%), whereas theNCEP criterion resulted in more balanced sensitivity and
specificity estimates and classified participants according
to their diabetes status twice as good as the IDF values.
In turn, a 0.5 WHtR threshold resulted in very poor spe-
cificity in this study.
In supplementary analyses, height, but not sitting-
height ratio, was shown to be significantly associated
with a decreased risk of T2DM both in men and women,
regardless of total body weight or waist circumference
(Additional file 1: Table S1). Predicted T2DM risk was
consistently higher at incresing BMI WHO categories,
Table 4 Area under the curve (AUC) for different anthropometrical variables as predictors of incident diabetes in men
and women from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort
AUC SE 95% CI Optimal cutoff1 Sensitivity Specificity
MEN
Body mass index (kg/m2) 0.676 0.008 0.660 - 0.691 28.7 66.7% 59.9%
Waist circumference (cm) 0.672 0.008 0.657 - 0.687 99.4 69.5% 55.8%
Waist-to-hip ratio 0.646 0.008 0.631 - 0.661 0.95 68.9% 53.2%
Waist-to-height ratio 0.687 0.008 0.673 - 0.702 0.60 66.1% 61.2%
WOMEN
Body mass index (kg/m2) 0.759 0.006 0.746 - 0.771 29.2 71.8% 66.9%
Waist circumference (cm) 0.773 0.006 0.760 - 0.785 90.4 74.5% 67.6%
Waist-to-hip ratio 0.722 0.007 0.708 - 0.735 0.84 71.0% 61.9%
Waist-to-height ratio 0.776 0.006 0.764 - 0.788 0.58 76.6% 65.6%
SE: standard error, CI: confidence interval.
1 Maximum Youden index (J) value (J = sensitivity + specificity - 1).
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according to the NCEP-ATPIII criterion (Additional
file 1: Table S2). Results did not change after further ad-
justment for dietary variables or exclusion of participants
with chronic conditions at baseline (Additional file 1:
Table S3). However, evidence of heterogeneity existed by
follow-up strata, and by groups of age and menopausalTable 5 Comparison of predefined anthropometric cut-
offs for predicting incident diabetes in men and women
from the Spanish EPIC (European Prospective
Investigation into Cancer and Nutrition) cohort
Sensitivity Specificity Correctly
classified1
MEN
Body mass index≥ 25 kg/m2 94.7% 14.7% 22.0%
Body mass index≥ 30 kg/m2 49.9% 74.1% 71.9%
IDF waist circumference
(WC≥ 94 cm)
89.6% 28.4% 34.0%
NCEP waist circumference
(WC≥ 102 cm)
57.5% 66.2% 65.4%
Waist-to-hip ratio ≥ 0.90 94.4% 16.8% 23.8%
Waist-to-height ratio≥ 0.5 98.8% 4.8% 13.4%
WOMEN
Body mass index≥ 25 kg/m2 94.2% 29.5% 33.0%
Body mass index≥ 30 kg/m2 64.4% 72.5% 72.1%
IDF waist circumference
(WC≥ 80 cm)
96.1% 29.3% 32.8%
NCEP waist circumference
(WC≥ 88 cm)
82.0% 58.2% 59.5%
Waist-to-hip ratio ≥ 0.85 64.4% 68.4% 68.2%
Waist-to-height ratio≥ 0.5 97.6% 26.3% 30.1%
NCEP: national cholesterol education program, IDF: international
diabetes federation.
1 Proportion of participants with correctly classified diabetes status according
to the respective cut-off point of each binary anthropometric
variable considered.status. The effect of a larger WC on T2DM risk was evalu-
ated separately in normal weight, overweight and obese
participants (Additional file 1: Table S4). Women pre-
sented higher risk estimates at high WC values, with obese
participants of large WC (≥ 88 cm) showing up to 5.6-fold
times higher risk of diabetes than their normal weight, low
WC (< 80 cm) counterparts (versus 2.8 times higher risk in
men). Of note, less than 5% of women with normal WC be-
came diabetic after 10 years of follow-up, even if obese and
in the 60–69 years old group (Additional file 1: Table S5).
Absolute risks were higher in men than women for any
age, waist and BMI category. The population risk of dia-
betes attributable to excess body weight (BMI ≥ 25 kg/m2)
in the EPIC-Spain cohort was estimated in 46% (95% CI,
33 - 59%) for men and 61% (95% CI, 52 - 71%) for women
(Additional file 1: Table S6). If only obesity were targeted,
the proportion of avoidable cases would reach an estima-
ted 17% (95% CI, 13 - 21%) in men and 31% (95% CI,
27 - 36%) in women.
The modelling of T2DM risk related to the anthropo-
metric indices evaluated using restricted cubic splines
revealed a similar pattern for the studied indices within
each sex, but appreciably different between sexes, show-
ing curvilinear relationships with steeper slopes in
women, while associations tended to reach a plateau at
highest anthropometric values in men (Figure 1).
Figure 2 shows the cumulative hazard of diabetes by
age for combined BMI and WC strata. Central obesity
added independently to the risk of diabetes in each BMI
category, but much more significantly in women, for
whom the estimated cumulative hazard of diabetes in
normal-waist participants remained below 15% even
among the oldest.
Discussion
General and central obesity were both independent pre-
dictors of T2DM risk in this large prospective cohort of
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(See figure on previous page.)
Figure 1 Relative risk of diabetes as a function of different anthropometric indices in men and women from the Spanish EPIC
(European Prospective Investigation into Cancer and Nutrition) cohort. Restricted cubic splines modelling of T2DM risk according to
variation in anthropometric variables, with knots at the 5th, 25th, 50th, 75th, and 95th percentiles. The reference (RR = 1, dashed line) was set at a
body mass index equal to 25 kg/m2 (A.1 and B.1), a waist circumference equal to 94 cm in men (A.2) or 80 cm in women (B.2), a waist-to-hip
ratio equal to 0.90 in men (A.3) or 0.85 in women (B.3), and a waist-to-height ratio equal to 0.50 (A.4 and B.4).
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at elevated values of BMI and WC were higher for women
than for men. Also central obesity, although a moderate
independent predictor of T2DM in men, showed the
strongest association with diabetes in women. The meas-
ure of waist circumference in the clinical practice would
thus be a valuable and inexpensive aid in the evaluation of
diabetes risk, especially for women.
The practical need to distinguish between general and
central obesity from an anthropometric perspective, raises
the question about which indicator would be the best
proxy for central obesity either in clinical and epidemio-
logical settings. Literature showed that relative measures of
WC, such as the waist-to-hip ratio, predicted risk of dis-
ease no better than WC alone [22], which guided the defin-
ition of central obesity to rely exclusively on WC [29,30].
But recent findings have given support to the use of WHtR
as a better central obesity index in the prediction of T2DM
among different ethnic groups [26,28,37-39]. Height influ-
ences the shape and frame size of individuals, and the evi-
dence suggests that taller people tend to be leaner (and
meager) than their shorter counterparts [24]. In the
present study, taller participants had around 25% reduced
risk of becoming diabetic independently of their weight
and abdominal perimeter. Since height is also conceived as
a proxy indicator of childhood nutritional status, its strong
association with diabetes may thus integrate a double di-
mension of actual physical characteristics and infancy
socio-economic circumstances [40]. Our results supports
waist-to-height ratio as the best single measure to predict
risk of diabetes, presenting the largest area under the ROC
curve in both sexes (AUCmen = 0.69; AUCwomen = 0.78), in
line with previous evidence, with an optimal cut-off value
of 0.6, above the proposed threshold of 0.5 [37]. The
consistency of the predictive ability of WHtR with regard
to T2DM across different ethnic backgrounds, and sex
groups, together with its simplicity, supports including this
promising index systematically in future epidemiological
studies in the field of diabetes and other chronic diseases
[37,41]. However, the definition of universal clinical thresh-
olds (if at all possible) still warrants further investigation in
different age groups and disease contexts. From a clinical
point of view, although waist measures provide no dra-
matic gain in discriminatory ability as compared to BMI,
given their independent and graded association with
T2DM, the authors firmly believe that it deserves consider-
ation the inclusion of central obesity measures (WC thesimplest, WHtR the most discriminative) in clinical prac-
tice guidelines for the management of T2DM patients to
assist diagnosis and decision-making by the physician, at
least in the case of female patients. The combination of
BMI and WC would allow a much more accurate ranking
of individuals according to their disease risk. Our results
show large differences in 10-year absolute risk of T2DM
between normal-waist and high-waist female participants,
further supporting the relevance of WC as a complemen-
tary measure for evaluating diabetes risk in women.
As a point for discussion, no specific cut-off points have
yet been adopted to define central obesity in Spain. With
regard to diabetes, our results suggest optimal cut-offs at
99 cm in men and 90 cm in women. Two other criteria for
defining central obesity are available which are most-
ly used in the diagnosis of metabolic syndrome, those
proposed by the IDF for European population (94/80 cm)
[30] and those of the NCEP-ATPIII (102/88 cm) [29].
Although less sensitive, the NCEP-ATPIII criterion was
much more specific when applied to our cohort; besides,
the IDF criterion failed to correctly classify a large propor-
tion of the sample. Until adapted, specific values are
defined, our data strongly supports the adoption of
NCEP-ATPIII values in the Spanish population to enable
international comparability of country data.
Obesity, both general and central, had a greater influ-
ence on the risk of T2DM in women than men, consistent
with previous evidence [2]. Genetic effects determine sex
differences in body composition [42] and hormonal factors
[43] have been invoked to account for the weaker associ-
ation between obesity and T2DM in men. However, rea-
sons for this sex-specific effect are not clear. A gynoid fat
pattern, characterised by fat tissue depots in thighs and
hip, has been shown to be inversely associated to fasting
and postload glucose concentrations, and to diabetes risk,
independently of BMI and waist circumference [44].
Larger thigh and hip circumferences in women could re-
flect increased femoral and gluteal subuctaneous fat mass,
which have been reported to show high lipoprotein lipase
activity and low lipolytic activity [44,45], thus contributing
to fatty acid uptake and storage [45]. In turn, abdominal
fat depots are more strongly related to insulin resistance
than periferal or gluteal adiposity by releasing larger
amounts of free fatty acids into the blood that become
lipotoxic for hepatic and muscle cells [11,46]. Thus,
women with an android fat pattern (a pattern of central
adiposity) might be at higher relative risk of T2DM
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0.
00
0.
10
0.
20
0.
30
0.
40
0.
50
0.
60
30 40 50 60 70 80
Age (years)
Normal weight, no central obesity Normal weight, central obesity
Overweight, no central obesity Overweight, central obesity
Obese, no central obesity Obese, central obesity
0.
00
0.
10
0.
20
0.
30
0.
40
0.
50
0.
60
30 40 50 60 70 80
Age (years)
Normal weight, no central obesity Normal weight, central obesity
Overweight, no central obesity Overweight, central obesity
Obese, no central obesity Obese, central obesity
Figure 2 Nelson-Aalen cumulative hazard estimates of diabetes by combined strata of body mass index and waist circumference in
men (A) and women (B) from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort. Body mass index
strata (normal weight, overweight, obese) were defined according to WHO standard body mass index groups (< 25, 25-29.99, ≥ 30 kg/m2); waist
circumference strata were based on the presence of central obesity, defined by a waist circumference ≥ 102 cm in men or a waist circumference
≥ 88 cm in women.
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fat and a reduced ‘protection’ by hip and thigh fat depots,
as compared to gynoid females. In support of the latter,
Cameron et al. have recently shown the important con-
founding effect of hip circumference in the association be-
tween central obesity and all-cause and cardiovascular
mortality, hip circumference being inversely associated to
mortality after adjustment by waist circumference [47]. In
our study, hip circumference was no longer associated to
diabetes risk once weight and waist circumference were
accounted for in categorical models, but it showed a sig-
nificant independent inverse relationship with diabetes in
a continuous model (HRmen, per standard deviation = 0.90, 95%
CI, 0.82 - 0.99; HRwomen, per standard deviation = 0.73, 95% CI,
0.65 - 0.83; data not shown), which points out to a pro-
tective independent effect of hip circumference similar to
that suggested by previous authors [44,47]. These results
highlight the aetiological role of central obesity in promot-
ing T2DM, but also revive the discussion on the import-
ance of hip circumference as an independent predictor of
chronic disease and mortality, especially among women.
The large and increasing prevalence of overweight and
obesity, and the ageing of the population in Spain, as in
many other countries [6,7,48], raises serious concerns
about the future burden of diabetes morbidity and mor-
tality. In our study, we have estimated that around 46%
of cases among men, and 61% of cases among women,
could be avoided by maintaining a normal weight (BMI
< 25 kg/m2). If our relative risk estimates were extrapo-
lated to the general Spanish population, using the most
accurate and up-to-date nation-wide figures available for
Spain (an overall prevalence of overweight or obesity of
70.8% and 53.9% for men and women respectively [49]),
the proportion of diabetes cases that could be avoided if
the population kept a normal weight could be calculated
in 40.1% (95% CI, 27.3 - 52.9%) in men and 49.7% in
women (95% CI, 38.9 - 60.4%). Even further gains are
conceivable if lower reductions in BMI or abdominal
girth were achieved. However, further extrapolation of
these results must be applied with caution, since preva-
lences and relative risk estimates may vary in other
settings.
Some limitations should be considered when interpret-
ing these data. The EPIC-Spain sample was not repre-
sentative of the general population, consisted of a large
proportion of blood donors and included predominantly
women, which would limit the generalizability of the
results. Furthermore, the prevalence of elevated BMI in
this cohort was very high as compared to other popula-
tions, particularly those from Asian origin [50], this
meaning that the estimated risks (relative and aboslute)
and cut-off values obtained should not be directly extra-
polated to populations of different geographical, ethnic,
or cultural contexts. Unfortunately, no data was availableon family history of diabetes, and thus the genetic back-
ground of participants could not be accounted for in the
analyses. The limited availability of primary care data in
one of the study centres might not have resulted in a
significant misclassification bias, however, since the asso-
ciations remained unchanged after excluding the partici-
pants from this centre in a sensitivity analysis. Finally,
since no additional anthropometric measures were per-
formed during the follow-up, the possibility that partici-
pants could have lost or put on weight after recruitment
could not be evaluated. Furthermore, it was not possible
to assess to what extent potential reductions in weight
or WC during the study period would be able to
decrease T2DM risk in this population. Important
strengths are the large sample size, the prospective de-
sign with a long follow-up time, and the use of an-
thropometric measures, not self-reports. Also, the large
number of cases available allowed for robust estimates
of T2DM risk across the full range of relevant anthropo-
metric indicators. Finally, a large set of confounders was
available to control for, including dietary and lifestyle
variables, and mis-reporting of energy intake.Conclusion
Diabetes risk was consistently associated with higher
overall and central obesity indices in adult population,
even at BMI and WC values regarded as normal. The
study provides specific estimates of diabetes risk (abso-
lute and relative) by categories of anthropometric vari-
ables in Spanish men and women, makes the importance
of central adiposity indices manifest, especially for
women, and promotes the measurement of waist cir-
cumference in the clinical setting to assist the evaluation
of metabolic risk.Additional file
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